The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis.
Open accessAbstract
Stromelysin is a member of the family of metalloproteinases that degrade extracellular matrix. In situ hybridisation and histopathological studies suggest that stromelysin activity may be important in the connective tissue remodelling processes associated with atherogenesis and plaque rupture. Single strand conformation polymorphism analysis identified a common polymorphism in the stromelysin gene promoter located 1171 bp upstream from the start of transcription in which one allele has a run of six adenosines (6A) and another has five adenosines (5A). 72 men with coronary heart disease, were genotyped. They were participants in the St Thomas' Atherosclerosis Regression Study who were randomised to receive usual care (UC), dietary intervention (D), or diet plus cholestyramine (DC), with angiography at baseline and at 39 months. In these patients the frequency of the 5A allele was 0.49 (95% CI from 0.41 to 0.57) and was not significantly different from that in a sample of 354 healthy UK men. In the UC group, patients who were homozygous for the 6A allele showed greater progression of angiographic disease than those with other genotypes: the minimum absolute width of coronary segments decreased by 0.04 (SEM 0.10) mm for 5A5A, 0.20 (0.07) mm for 5A6A, and 0.67 (0.19) mm for 6A6A (P < 0.01). The findings were similar but slightly less significant for the change in mean absolute width of coronary segments (P < 0.05). No significant associations were seen in patients in the D or DC groups. In data pooled from the three treatment groups, the 6A6A genotype was significantly associated with greater progression of coronary atherosclerosis than other genotypes in patients with baseline percentage diameter stenosis less than 20% (P < 0.05), but not in those with baseline percentage diameter stenosis greater than or equal to 20%. These results provide the first evidence of a link between genetic variation in stromelysin and progression of coronary atherosclerosis and support the hypothesis that connective tissue remodeling mediated by metalloproteinases contribute to the pathogenesis of atherosclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A simple salting out procedure for extracting DNA from human nucleated cells
Miller, S. A., Dykes, D. D., & Polesky, H. F. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.3.1215 · Cited by 20,330
The Pathogenesis of Atherosclerosis — An Update
Ross, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602203140806 · Cited by 4,877
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
Epstein, F. H., Fuster, V., Badimon, L., Badimon, J. J., & Chesebro, J. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201303260506 · Cited by 3,725
Matrix metalloproteinases and their inhibitors in connective tissue remodeling
Woessner, J. F. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.8.1850705 · Cited by 3,282
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
Epstein, F. H., Fuster, V., Badimon, L., Badimon, J. J., & Chesebro, J. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201233260406 · Cited by 2,717
The pathogenesis of coronary artery disease and the acute coronary syndromes (First of two parts)
Fuster, V. (1992) · New England Journal of Medicine · Cited by 1,954
Little, W. C., Constantinescu, M., Applegate, R. J., Kutcher, M. A., Burrows, M. T., Kahl, F. R., & Santamore, W. P. (1988) · Circulation · doi:10.1161/01.cir.78.5.1157 · Cited by 1,474
RICHARDSON, P. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90953-7 · Cited by 1,258
Connective Tissue and Its Heritable Disorders: Molecular, Genetic, and Medical Aspects
(2002) · Wiley eBooks · doi:10.1002/0471221929 · Cited by 949
Watts, G. F., Lewis, B., Lewis, E. S., Coltart, D. J., Smith, L. D. R., Swan, A. V., Brunt, J. N. H., & Mann, J. I. (1992) · The Lancet · doi:10.1016/0140-6736(92)90863-x · Cited by 843
Self-citationLocalization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization.
Henney, A. M., Wakeley, P. R., Davies, M. J., Foster, K., Hembry, R., Murphy, G., & Humphries, S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.18.8154 · Cited by 590
Self-citationDawson, S. J., Wiman, B., Hamsten, A., Green, F., Humphries, S., & Henney, A. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82047-6 · Cited by 569
Self-citationAngiographic evolution of coronary artery morphology in unstable angina
Ambrose, J. A., Winters, S. L., Arora, R. R., Eng, A., Riccio, A., Gorlin, R., & Fuster, V. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80455-7 · Cited by 460
Atherosclerotic plaque rupture and thrombosis. Evolving concepts.
Fuster, V., Stein, B., Ambrose, J. A., Badimón, L., Badimón, J. J., & Chesebro, J. H. (1990) · PubMed · Cited by 454
TGF-β1 inhibition of transin/stromelysin gene expression is mediated through a fos binding sequence
Kerr, L. D., Miller, D. B., & Matrisian, L. M. (1990) · Cell · doi:10.1016/0092-8674(90)90807-q · Cited by 439
A macro and micro view of coronary vascular insult in ischemic heart disease.
Mj, D. (1990) · PubMed · Cited by 403
DAVIES, M. J., BLAND, J. M., HANGARTNER, J. R. W., ANGELINA, A., & THOMAS, A. C. (1989) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a059467 · Cited by 397
Nicholson, R. C., Mader, S., Nagpal, S., Leid, M., Rochette-Egly, C., & Chambon, P. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07895.x · Cited by 370
Kerr, L. D., Holt, J. T., & Matrisian, L. M. (1988) · Science · doi:10.1126/science.2462278 · Cited by 277
Frisch, S., & Ruley, H. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)49254-x · Cited by 213
Mackay, A. R., Ballin, M., Pelina, M. D., Farina, A. R., Nason, A. M., Hartzler, J. L., & Thorgeirsson, U. P. (1992) · PubMed · Cited by 201
de Feyter, P. J., Serruys, P. W., Davies, M. J., Richardson, P., Lubsen, J., & Oliver, M. F. (1991) · Circulation · doi:10.1161/01.cir.84.1.412 · Cited by 185
Physiological mechanisms for metalloproteinase activation.
Murphy, G., Ward, R., Gavrilović, J., & Atkinson, S. J. (1992) · PubMed · Cited by 138
STUDIES OF REGRESSION OF ADVANCED ATHEROSCLEROSIS IN EXPERIMENTAL ANIMALS AND MAN*
Wissler, R. W., & Vesselinovitch, D. (1976) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1976.tb43368.x · Cited by 124
Transcriptional regulation of human stromelysin
Quiñones, S., Saus, J., Otani, Y., Harris, E. D., & Kurkinen, M. T. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83187-8 · Cited by 120
Butticè, G., Quiñones, S., & Kurkinen, M. T. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.13.3723 · Cited by 120
Butticè, G., & Kurkinen, M. T. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53164-1 · Cited by 113
Humphries, S. E., Lane, A., Green, F. R., Cooper, J. A., & Miller, G. J. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.2.193 · Cited by 102
Self-citationSirum-Connolly, K., & Brinckerhoff, C. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.2.335 · Cited by 86
Rouis, M., Nigon, F., Lafuma, C., Hornebeck, W., & Chapman, M. J. (1990) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.10.2.246 · Cited by 72
Case, J. P., Lafyatis, R., Kumkumian, G., Remmers, E. F., & Wilder, R. L. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.11.3755 · Cited by 70
Symposium on regression of atherosclerosis
Moncada, S., Martin, J., & Higgs, A. (1993) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1993.tb00781.x · Cited by 27
Primary prevention of atherosclerosis by lovastatin in a genetically hyperlipidaemic rabbit strain
Ville, A. E. L., Seddon, A. M., Shaikh, M., Rowles, P. M., Woolf, N., & Lewis, B. (1989) · Atherosclerosis · doi:10.1016/0021-9150(89)90224-4 · Cited by 24
Cited by
Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: The Good, the Bad, and the Ugly
Galis, Z. S., & Khatri, J. J. (2002) · Circulation Research · doi:10.1161/res.90.3.251 · Cited by 1,548
Biochemical and Biological Attributes of Matrix Metalloproteinases
Cui, N., Hu, M., & Khalil, R. A. (2017) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2017.02.005 · Cited by 1,359
Matrix Metalloproteinases and Cardiovascular Disease
Dollery, C. M., McEwan, J. R., & Henney, A. M. (1995) · Circulation Research · doi:10.1161/01.res.77.5.863 · Cited by 864
Self-citationNewby, A. C. (2005) · Physiological Reviews · doi:10.1152/physrev.00048.2003 · Cited by 817
Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease
Wang, X., & Khalil, R. A. (2018) · Advances in Pharmacology · doi:10.1016/bs.apha.2017.08.002 · Cited by 754
Metadata
- Authors
- Ye, S., Watts, G. F., Mandalia, S., Humphries, S. E., & Henney, A. M.
- Venue
- Heart
- Publisher
- BMJ
- Published
- 1995-03-01
- Volume
- 73
- Issue
- 3
- Pages
- 209-215
- ISSN
- 1355-6037 (ISSN-L)
- OpenAlex
- W2115911961
- Cited by
- 259
- References
- 33
- FWCI
- 3.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.